<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="94ae6054-b7ae-4212-a567-4f803af8f2c7"><labelDrug name="Lotrel"><Normalization><mmtx cui="C0721438" preferredWord="Lotrel" semType="phsu, orch"/></Normalization></labelDrug><generic name="amlodipine besylate and benazepril hydrochloride"/><sentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.1" text="Drug Label for drug brand Lotrel, containing amlodipine besylate and benazepril hydrochloride." type="negative"><entity charOffset="69:93" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.1.e.0" text="benazepril hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0770917" phraseText="benazepril hydrochloride." preferredWord="Benazepril hydrochloride" semType="phsu, orch"/><RxNorm RxCui="18867"/></Normalization></entity><entity charOffset="26:32" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.1.e.1" text="lotrel" type="Biomedical_Entity"><Normalization><mmtx cui="C0721438" phraseText="Drug Label for drug brand Lotrel," preferredWord="Lotrel" semType="phsu, orch"/><RxNorm RxCui="218090"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.1.e.2" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Lotrel," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="45:64" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.1.e.3" text="amlodipine besylate" type="Biomedical_Entity"><Normalization><mmtx cui="C0354468" phraseText="amlodipine besylate" preferredWord="Amlodipine Besylate" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.1.e.1" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.1.e.0"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.1.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.1.e.0"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.1.e.3" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.1.e.0"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.1.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.1.e.1"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.1.e.1" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.1.e.3"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.1.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.1.e.3"/></sentence><sentence biomedicalEntities="4" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9" lineNumber="16" text="&lt;item&gt;Do not co-administer aliskiren with angiotensin receptor blockers, ACE inhibitors, including Lotrel in patients with diabetes." type="regular"><entity charOffset="6:26" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.1" text="Do not co-administer" type="Caution_Interaction"/><entity charOffset="42:71" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.2" text="angiotensin receptor blockers" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="aliskiren with angiotensin receptor blockers," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="aliskiren with angiotensin receptor blockers," preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="27:36" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.3" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with angiotensin receptor blockers," preferredWord="aliskiren" semType="phsu, orch"/><mmtx cui="C1120110" phraseText="aliskiren with angiotensin receptor blockers," preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="123:131" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes." preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes." preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><entity charOffset="73:87" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.5" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="99:105" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.7" text="Lotrel" type="Drug"><Normalization><mmtx cui="C0721438" phraseText="Lotrel in patients" preferredWord="Lotrel" semType="phsu, orch"/><RxNorm RxCui="218090"/></Normalization></entity><drugClassMembership drug="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.7" drugClass="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.5"/><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.5"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.4" ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.3" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.2" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.1" type="Caution_Interaction"/><pair context="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.4" ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.3" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.5" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.9.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10" text="&lt;item&gt;Lotrel is contraindicated in patients with a history of angioedema, with or without previous ACE inhibitor treatment, or patients who are hypersensitive to benazepril, to any other ACE inhibitor, to amlodipine, or to any of the excipients of Lotrel." type="negative"><entity charOffset="6:12" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.0" text="lotrel" type="Biomedical_Entity"><Normalization><mmtx cui="C0721438" phraseText="&gt;Lotrel" preferredWord="Lotrel" semType="phsu, orch"/><RxNorm RxCui="218090"/></Normalization></entity><entity charOffset="187:200" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.1" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="other ACE inhibitor," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="99:112" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.2" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="or without previous ACE inhibitor treatment," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="205:215" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.3" text="amlodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0051696" phraseText="to amlodipine," preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="162:172" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.4" text="benazepril" type="Biomedical_Entity"><Normalization><mmtx cui="C0053091" phraseText="hypersensitive to benazepril," preferredWord="benazepril" semType="phsu, orch"/><RxNorm RxCui="18867"/></Normalization></entity><entity charOffset="248:254" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.5" text="lotrel" type="Biomedical_Entity"><Normalization><mmtx cui="C0721438" phraseText="or to any of the excipients of Lotrel." preferredWord="Lotrel" semType="phsu, orch"/><RxNorm RxCui="218090"/></Normalization></entity><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.0" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.1"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.0" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.2"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.0" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.3"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.0" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.4"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.1" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.3"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.4" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.1"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.1" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.5"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.3"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.4"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.5"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.4" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.3"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.3" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.5"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.4" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.10.e.5"/></sentence><sentence biomedicalEntities="4" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11" lineNumber="24" text="&lt;item&gt;Do not co-administer aliskiren with ARBs or ACEIs, including Lotrel, in patients with diabetes (4)" type="regular"><entity charOffset="6:26" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.1" text="Do not co-administer" type="Caution_Interaction"/><entity charOffset="27:36" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with ARBs" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="42:46" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.3" text="ARBs" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="92:100" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><entity charOffset="50:55" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.5" text="ACEIs" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="67:73" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.7" text="Lotrel" type="Drug"><Normalization><mmtx cui="C0721438" phraseText="Lotrel," preferredWord="Lotrel" semType="phsu, orch"/><RxNorm RxCui="218090"/></Normalization></entity><drugClassMembership drug="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.7" drugClass="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.5"/><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.5"/></relation><relation type="hasContext"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.4" ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.3" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.1" type="Caution_Interaction"/><pair context="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.4" ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.5" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.11.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12" text="&lt;item&gt;Lotrel is contraindicated in patients with a history of angioedema, with or without previous ACE inhibitor treatment, or patients who are hypersensitive to benazepril, to any other ACE inhibitor, or to amlodipine. " type="negative"><entity charOffset="162:172" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.0" text="benazepril" type="Biomedical_Entity"><Normalization><mmtx cui="C0053091" phraseText="hypersensitive to benazepril," preferredWord="benazepril" semType="phsu, orch"/><RxNorm RxCui="18867"/></Normalization></entity><entity charOffset="187:200" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.1" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="other ACE inhibitor," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="6:12" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.2" text="lotrel" type="Biomedical_Entity"><Normalization><mmtx cui="C0721438" phraseText="&gt;Lotrel" preferredWord="Lotrel" semType="phsu, orch"/><RxNorm RxCui="218090"/></Normalization></entity><entity charOffset="208:218" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.3" text="amlodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0051696" phraseText="to amlodipine." preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="99:112" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.4" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="or without previous ACE inhibitor treatment," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.0" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.1"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.0"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.0" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.3"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.4" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.0"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.1"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.1" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.3"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.3"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.4"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.4" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.12.e.3"/></sentence><sentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.21" text="Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including Lotrel) may be subject to a variety of adverse reactions, some of them serious. " type="negative"><entity charOffset="193:199" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.21.e.0" text="lotrel" type="Biomedical_Entity"><Normalization><mmtx cui="C0721438" phraseText="Lotrel" preferredWord="Lotrel" semType="phsu, orch"/><RxNorm RxCui="218090"/></Normalization></entity><entity charOffset="167:181" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.21.e.1" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="19:59" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.21.e.2" text="angiotensin-converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="angiotensin-converting enzyme inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.21.e.1" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.21.e.0"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.21.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.21.e.0"/></sentence><sentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.31" text="The angioedema was diagnosed by procedures including abdominal CT scan or ultrasound, or at surgery, and symptoms resolved after stopping the ACE inhibitor. " type="negative"><entity charOffset="129:137" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.31.e.0" text="stopping" type="Biomedical_Entity"><Normalization><mmtx cui="C0723457" phraseText="resolved after stopping" preferredWord="Stop brand of fluoride" semType="inch, phsu"/><RxNorm RxCui="220037"/></Normalization></entity><entity charOffset="142:155" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.31.e.1" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="the ACE inhibitor." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.31.e.0" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.31.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.33" lineNumber="54" text="Anaphylactoid Reactions During Desensitization: Two patients undergoing desensitizing treatment with hymenoptera venom while receiving ACE inhibitors sustained life-threatening anaphylactoid reactions. " type="regular"><entity charOffset="177:200" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.33.e.1" text="anaphylactoid reactions" type="Specific_Interaction"/><entity charOffset="101:118" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.33.e.2" text="hymenoptera venom" type="Substance"><Normalization><mmtx cui="C1290000" phraseText="desensitizing treatment with hymenoptera venom" preferredWord="Hymenoptera venom" semType="phsu"/><RxNorm RxCui="390053"/></Normalization></entity><entity charOffset="135:149" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.33.e.3" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="receiving ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="160:176" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.33.e.4" text="life-threatening" type="SPAN"/><entity charOffset="48:60" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.33.e.5" text="Two patients" type="SPAN"/><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.33.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.33.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.33.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.33.e.3"/></relation><relation type="hasSeverity"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.33.e.4"/></relation><relation type="hasEvidence"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.33.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.33.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.33.e.3" evidence="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.33.e.5" severity="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.33.e.4" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.33.e.1" type="Specific_Interaction"/></sentence><sentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.40" text="As with all other vasodilators, special caution is required when using amlodipine in patients suffering from aortic or mitral stenosis, or obstructive hypertrophic cardiomyopathy." type="negative"><entity charOffset="71:81" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.40.e.0" text="amlodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0051696" phraseText="amlodipine in patients" preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="18:30" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.40.e.1" text="vasodilators" type="Biomedical_Entity"><Normalization><mmtx cui="C0042402" phraseText="other vasodilators," preferredWord="Vasodilator Agents" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.40.e.1" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.40.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.48" lineNumber="68" text="In such patients, start Lotrel therapy under close medical supervision, follow closely for the first 2 weeks of treatment and whenever the dose of the benazepril component is increased or a diuretic is added or its dose increased." type="regular"><entity charOffset="72:78" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.48.e.1" text="follow" type="Caution_Interaction"/><entity charOffset="190:198" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.48.e.2" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="a diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="151:161" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.48.e.3" text="benazepril" type="Drug"><Normalization><mmtx cui="C0053091" phraseText="the dose of the benazepril component" preferredWord="benazepril" semType="phsu, orch"/><RxNorm RxCui="18867"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.48.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.48.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.48.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.48.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.48.e.3" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.48.e.2" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.48.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.63" lineNumber="82" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or who are on NSAIDS or angiotensin receptor blockers may be at particular risk of developing acute renal failure on Lotrel. " type="regular"><entity charOffset="305:324" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.63.e.1" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="be at particular risk of developing acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><entity charOffset="225:231" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.63.e.2" text="NSAIDS" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="are on NSAIDS" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="328:334" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.63.e.3" text="Lotrel" type="Drug"><Normalization><mmtx cui="C0721438" phraseText="on Lotrel." preferredWord="Lotrel" semType="phsu, orch"/><RxNorm RxCui="218090"/></Normalization></entity><entity charOffset="235:264" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.63.e.4" text="angiotensin receptor blockers" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="angiotensin receptor blockers" preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="angiotensin receptor blockers" preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.63.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.63.e.1"><relations><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.63.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.63.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.63.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.63.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.63.e.3" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.63.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.63.e.4" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.63.e.3" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.63.e.1" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.63.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.63.e.4"/></sentence><sentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.66" text="Monitor serum potassium periodically in patients receiving Lotrel. " type="negative"><entity charOffset="59:65" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.66.e.0" text="lotrel" type="Biomedical_Entity"><Normalization><mmtx cui="C0721438" phraseText="Lotrel." preferredWord="Lotrel" semType="phsu, orch"/><RxNorm RxCui="218090"/></Normalization></entity><entity charOffset="14:23" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.66.e.1" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="Monitor serum potassium periodically in patients" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.66.e.1" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.66.e.0"/></sentence><sentence biomedicalEntities="3" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.68" lineNumber="86" text="Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements, and/or potassium-containing salt substitutes. " type="irregular"><entity charOffset="36:48" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.68.e.1" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="153:174" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.68.e.2" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements," preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="124:151" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.68.e.3" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="the concomitant use of potassium-sparing diuretics," preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="183:220" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.68.e.4" text="potassium-containing salt substitutes" type="Substance"><Normalization><mmtx cui="C0597277" phraseText="potassium-containing salt substitutes." preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0784217" phraseText="potassium-containing salt substitutes." preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.68.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.68.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.68.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.68.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.68.e.4"/></relation><relation type="hasObject"><labelDrug text="Lotrel"/><normalization><mmtx><preferredWord>Lotrel</preferredWord><phraseText>Lotrel in patients</phraseText><cuiCode>C0721438</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.68.e.3" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.68.e.2"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.68.e.3" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.68.e.4"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.68.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.68.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.68.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.68.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.68.e.4"/></sentence><sentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.69" text="In U.S. placebo-controlled trials of Lotrel, hyperkalemia (serum potassium at least 0.5 mEq/L greater than the upper limit of normal) not present at baseline occurred in approximately 1.5% of hypertensive patients receiving Lotrel. " type="negative"><entity charOffset="37:43" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.69.e.0" text="lotrel" type="Biomedical_Entity"><Normalization><mmtx cui="C0721438" phraseText="of Lotrel," preferredWord="Lotrel" semType="phsu, orch"/><RxNorm RxCui="218090"/></Normalization></entity><entity charOffset="224:230" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.69.e.1" text="lotrel" type="Biomedical_Entity"><Normalization><mmtx cui="C0721438" phraseText="Lotrel." preferredWord="Lotrel" semType="phsu, orch"/><RxNorm RxCui="218090"/></Normalization></entity><entity charOffset="65:74" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.69.e.2" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="(serum potassium at least 0.5 mEq/L" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.69.e.0" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.69.e.2"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.69.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.69.e.1"/></sentence><sentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.75" text="In patients undergoing surgery or during anesthesia with agents that produce hypotension, benazepril will block the angiotensin II formation that could otherwise occur secondary to compensatory renin release. " type="negative"><entity charOffset="90:100" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.75.e.0" text="benazepril" type="Biomedical_Entity"><Normalization><mmtx cui="C0053091" phraseText="benazepril" preferredWord="benazepril" semType="phsu, orch"/><RxNorm RxCui="18867"/></Normalization></entity><entity charOffset="116:130" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.75.e.1" text="angiotensin ii" type="Biomedical_Entity"><Normalization><mmtx cui="C0003009" phraseText="the angiotensin II formation" preferredWord="Angiotensin II" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="41:51" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.75.e.2" text="anesthesia" type="Biomedical_Entity"><Normalization><mmtx cui="C0002932" phraseText="or during anesthesia" preferredWord="Anesthetics" semType="phsu"/><RxNorm RxCui="239756"/></Normalization></entity><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.75.e.0" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.75.e.1"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.75.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.75.e.0"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.75.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.75.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.78" lineNumber="101" text="&lt;item&gt;Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia." type="irregular"><entity charOffset="67:79" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.78.e.1" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="6:27" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.78.e.2" text="Potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0597277" phraseText="&gt;Potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="30:57" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.78.e.3" text="Potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="/ Potassium-sparing diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.78.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.78.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.78.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.78.e.3"/></relation><relation type="hasObject"><labelDrug text="Lotrel"/><normalization><mmtx><preferredWord>Lotrel</preferredWord><phraseText>Lotrel in patients</phraseText><cuiCode>C0721438</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.78.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.78.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.78.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.78.e.3"/></sentence><sentence biomedicalEntities="1" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.79" lineNumber="103" text="&lt;item&gt;Lithium: Increased serum Lithium levels, toxicity symptoms." type="irregular"><entity charOffset="15:30|39:45" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.79.e.1" text="Increased serum levels" type="Increase_Interaction"/><entity charOffset="31:38" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.79.e.2" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Increased serum Lithium levels," preferredWord="Lithium" semType="phsu, elii"/><mmtx cui="C0023870" phraseText="Increased serum Lithium levels," preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="47:55" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.79.e.4" text="toxicity" type="Increase_Interaction"><Normalization><mmtx cui="C0858786" phraseText="toxicity symptoms." preferredWord="toxic symptom" semType="sosy"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.79.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.79.e.1"><relations><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.79.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.69" text="In U.S. placebo-controlled trials of Lotrel, hyperkalemia (serum potassium at least 0.5 mEq/L greater than the upper limit of normal) not present at baseline occurred in approximately 1.5% of hypertensive patients receiving Lotrel. "><entity charOffset="224:230" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.69.e.0" text="Lotrel" type="Drug"><Normalization><mmtx cui="C0721438" phraseText="Lotrel." preferredWord="Lotrel" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.70" text="Increases in serum potassium were generally reversible."/><middleSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.71" text="5.9 Cough"/><middleSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.72" text="Presumably due to the inhibition of the degradation of endogenous bradykinin, persistent nonproductive cough has been reported with all ACE inhibitors, generally resolving after discontinuation of therapy. "/><middleSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.73" text="Consider ACE inhibitor-induced cough in the differential diagnosis of cough."/><middleSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.74" text="5.10 Surgery/Anesthesia"/><middleSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.75" text="In patients undergoing surgery or during anesthesia with agents that produce hypotension, benazepril will block the angiotensin II formation that could otherwise occur secondary to compensatory renin release. "/><middleSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.76" text="Hypotension that occurs as a result of this mechanism can be corrected by volume expansion."/><middleSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.77" text="7 DRUG INTERACTIONS"/><middleSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.78" text="&lt;item&gt;Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia."/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.79.ddi.2"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.79.e.4"><relations><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.79.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.69" text="In U.S. placebo-controlled trials of Lotrel, hyperkalemia (serum potassium at least 0.5 mEq/L greater than the upper limit of normal) not present at baseline occurred in approximately 1.5% of hypertensive patients receiving Lotrel. "><entity charOffset="224:230" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.69.e.0" text="Lotrel" type="Drug"><Normalization><mmtx cui="C0721438" phraseText="Lotrel." preferredWord="Lotrel" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.70" text="Increases in serum potassium were generally reversible."/><middleSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.71" text="5.9 Cough"/><middleSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.72" text="Presumably due to the inhibition of the degradation of endogenous bradykinin, persistent nonproductive cough has been reported with all ACE inhibitors, generally resolving after discontinuation of therapy. "/><middleSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.73" text="Consider ACE inhibitor-induced cough in the differential diagnosis of cough."/><middleSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.74" text="5.10 Surgery/Anesthesia"/><middleSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.75" text="In patients undergoing surgery or during anesthesia with agents that produce hypotension, benazepril will block the angiotensin II formation that could otherwise occur secondary to compensatory renin release. "/><middleSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.76" text="Hypotension that occurs as a result of this mechanism can be corrected by volume expansion."/><middleSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.77" text="7 DRUG INTERACTIONS"/><middleSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.78" text="&lt;item&gt;Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia."/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="1" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.80" lineNumber="105" text="&lt;item&gt;Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur" type="irregular"><entity charOffset="23:38" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.80.e.1" text="facial flushing" type="Specific_Interaction"><Normalization><mmtx cui="C0016382" phraseText="facial flushing," preferredWord="Flushing" semType="sosy"/></Normalization></entity><entity charOffset="6:21" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.80.e.2" text="Injectable gold" type="Drug"><Normalization><mmtx cui="C0018026" phraseText="&gt;Injectable gold" preferredWord="Gold" semType="phsu, elii"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="40:46" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.80.e.4" text="nausea" type="Specific_Interaction"><Normalization><mmtx cui="C0027497" phraseText="nausea," preferredWord="Nausea" semType="sosy"/></Normalization></entity><entity charOffset="48:56" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.80.e.6" text="vomiting" type="Specific_Interaction"><Normalization><mmtx cui="C0042963" phraseText="vomiting" preferredWord="Vomiting" semType="sosy"/></Normalization></entity><entity charOffset="61:72" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.80.e.8" text="hypotension" type="Specific_Interaction"/><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.80.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.80.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.80.e.2"/></relation><relation type="hasObject"><labelDrug text="Lotrel"/><normalization><mmtx><preferredWord>Lotrel</preferredWord><phraseText>Lotrel in patients</phraseText><cuiCode>C0721438</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.80.ddi.2"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.80.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.80.e.2"/></relation><relation type="hasObject"><labelDrug text="Lotrel"/><normalization><mmtx><preferredWord>Lotrel</preferredWord><phraseText>Lotrel in patients</phraseText><cuiCode>C0721438</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.80.ddi.3"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.80.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.80.e.2"/></relation><relation type="hasObject"><labelDrug text="Lotrel"/><normalization><mmtx><preferredWord>Lotrel</preferredWord><phraseText>Lotrel in patients</phraseText><cuiCode>C0721438</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.80.ddi.4"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.80.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.80.e.2"/></relation><relation type="hasObject"><labelDrug text="Lotrel"/><normalization><mmtx><preferredWord>Lotrel</preferredWord><phraseText>Lotrel in patients</phraseText><cuiCode>C0721438</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.80.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.81" lineNumber="107" text="&lt;item&gt;NSAID: Risk of renal dysfunction, loss of antihypertensive effect (7.1)" type="irregular"><entity charOffset="21:38" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.81.e.1" text="renal dysfunction" type="Specific_Interaction"/><entity charOffset="6:11" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.81.e.2" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="&gt;NSAID" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="40:71" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.81.e.4" text="loss of antihypertensive effect" type="Specific_Interaction"/><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.81.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.81.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.81.e.2"/></relation><relation type="hasObject"><labelDrug text="Lotrel"/><normalization><mmtx><preferredWord>Lotrel</preferredWord><phraseText>Lotrel in patients</phraseText><cuiCode>C0721438</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.81.ddi.2"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.81.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.81.e.2"/></relation><relation type="hasObject"><labelDrug text="Lotrel"/><normalization><mmtx><preferredWord>Lotrel</preferredWord><phraseText>Lotrel in patients</phraseText><cuiCode>C0721438</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.81.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.82" lineNumber="109" text="&lt;item&gt;If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7.1)" type="regular"><entity charOffset="57:84" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.82.e.1" text="do not exceed doses greater" type="Caution_Interaction"/><entity charOffset="105:116" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.82.e.2" text="simvastatin" type="Drug"><Normalization><mmtx cui="C0989915" phraseText="greater than 20 mg daily of simvastatin" preferredWord="Simvastatin 20 MG" semType="clnd"/><RxNorm RxCui="36567"/></Normalization></entity><entity charOffset="45:55" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.82.e.3" text="amlodipine" type="Drug"><Normalization><mmtx cui="C0051696" phraseText="co-administered with amlodipine," preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.82.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.82.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.82.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.82.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.82.e.3" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.82.e.2" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.82.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.83" lineNumber="111" text="&lt;item&gt;Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.1)" type="irregular"><entity charOffset="91:102" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.83.e.1" text="hypotension" type="Specific_Interaction"/><entity charOffset="11:53" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.83.e.2" text="inhibition of the renin-angiotensin system" type="Drug_Class"><Normalization><mmtx cui="C0035100" phraseText="&gt;Dual inhibition of the renin-angiotensin system" preferredWord="Chymosin" semType="phsu, aapp, enzy"/><mmtx cui="C0003018" phraseText="&gt;Dual inhibition of the renin-angiotensin system" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="986536"/></Normalization></entity><entity charOffset="108:120" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.83.e.4" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="73:89" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.83.e.6" text="renal impairment" type="Specific_Interaction"><Normalization><mmtx cui="C0035078" phraseText="Increased risk of renal impairment," preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="Increased risk of renal impairment," preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.83.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.83.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.83.e.2"/></relation><relation type="hasObject"><labelDrug text="Lotrel"/><normalization><mmtx><preferredWord>Lotrel</preferredWord><phraseText>Lotrel in patients</phraseText><cuiCode>C0721438</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.83.ddi.2"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.83.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.83.e.2"/></relation><relation type="hasObject"><labelDrug text="Lotrel"/><normalization><mmtx><preferredWord>Lotrel</preferredWord><phraseText>Lotrel in patients</phraseText><cuiCode>C0721438</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.83.ddi.3"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.83.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.83.e.2"/></relation><relation type="hasObject"><labelDrug text="Lotrel"/><normalization><mmtx><preferredWord>Lotrel</preferredWord><phraseText>Lotrel in patients</phraseText><cuiCode>C0721438</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.83.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.86" lineNumber="119" text="Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin. " type="regular"><entity charOffset="62:93" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.86.e.1" text="increases the systemic exposure" type="Increase_Interaction"/><entity charOffset="97:108" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.86.e.2" text="simvastatin" type="Drug"><Normalization><mmtx cui="C0074554" phraseText="the systemic exposure of simvastatin." preferredWord="Simvastatin" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><entity charOffset="51:61" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.86.e.3" text="amlodipine" type="Drug"><Normalization><mmtx cui="C0051696" phraseText="with amlodipine" preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.86.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.86.e.1"><relations><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.86.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.86.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.86.e.3" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.86.e.2" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.86.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.87" lineNumber="119" text="Limit the dose of simvastatin in patients on amlodipine to 20 mg daily." type="regular"><entity charOffset="0:14" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.87.e.1" text="Limit the dose" type="Caution_Interaction"/><entity charOffset="18:29" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.87.e.2" text="simvastatin" type="Drug"><Normalization><mmtx cui="C0074554" phraseText="the dose of simvastatin" preferredWord="Simvastatin" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><entity charOffset="45:55" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.87.e.3" text="amlodipine" type="Drug"><Normalization><mmtx cui="C0051696" phraseText="on amlodipine" preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.87.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.87.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.87.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.87.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.87.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.87.e.3" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.87.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.88" lineNumber="120" text="CYP3A4 Inhibitors: Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. " type="regular"><entity charOffset="92:119" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.88.e.1" text="increased systemic exposure" type="Increase_Interaction"/><entity charOffset="42:58|60:68" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.88.e.2" text="CYP3A inhibitors moderate" type="Drug_Class"><Normalization><RxNorm RxCui="24348"/></Normalization></entity><entity charOffset="123:133" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.88.e.3" text="amlodipine" type="Drug"><Normalization><mmtx cui="C0051696" phraseText="results in increased systemic exposure to amlodipine" preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="73:79|42:58" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.88.e.4" text="strong CYP3A inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="608507"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.88.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.88.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.88.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.88.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.88.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.88.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.88.e.3" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.88.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.88.e.4" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.88.e.3" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.88.e.1" type="Increase_Interaction"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.88.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.88.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.89" lineNumber="120" text="Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A4 inhibitors to determine the need for dose adjustment." type="regular"><entity charOffset="24:35" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.89.e.1" text="hypotension" type="Specific_Interaction"/><entity charOffset="86:103" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.89.e.2" text="CYP3A4 inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="340933"/></Normalization></entity><entity charOffset="51:61" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.89.e.3" text="amlodipine" type="Drug"><Normalization><mmtx cui="C0051696" phraseText="amlodipine" preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="40:45" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.89.e.5" text="edema" type="Specific_Interaction"/><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.89.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.89.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.89.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.89.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.89.ddi.2"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.89.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.89.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.89.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.89.e.3" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.89.e.2" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.89.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.91" lineNumber="121" text="Blood pressure should be monitored when amlodipine is co-administered with CYP3A4 inducers." type="regular"><entity charOffset="25:34" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.91.e.1" text="monitored" type="Caution_Interaction"/><entity charOffset="75:90" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.91.e.2" text="CYP3A4 inducers" type="Drug_Class"><Normalization><RxNorm RxCui="340933"/></Normalization></entity><entity charOffset="40:50" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.91.e.3" text="amlodipine" type="Drug"><Normalization><mmtx cui="C0051696" phraseText="amlodipine" preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.91.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.91.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.91.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.91.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.91.e.3" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.91.e.2" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.91.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.93" lineNumber="123" text="Potassium Supplements and Potassium-Sparing Diuretics: Benazepril can attenuate potassium loss caused by thiazide diuretics. " type="regular"><entity charOffset="70:94" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.93.e.1" text="attenuate potassium loss" type="Specific_Interaction"/><entity charOffset="105:123" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.93.e.2" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="caused by thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="55:65" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.93.e.3" text="Benazepril" type="Drug"><Normalization><mmtx cui="C0053091" phraseText="Benazepril" preferredWord="benazepril" semType="phsu, orch"/><RxNorm RxCui="18867"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.93.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.93.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.93.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.93.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.93.e.3" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.93.e.2" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.93.e.1" type="Specific_Interaction"/></sentence><sentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94" text="Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia. " type="negative"><entity charOffset="0:27" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.0" text="potassium-sparing diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0304490" phraseText="Potassium-sparing diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="56:67" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.1" text="triamterene" type="Biomedical_Entity"><Normalization><mmtx cui="C0040869" phraseText="triamterene," preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="45:54" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.2" text="amiloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0002502" phraseText="amiloride," preferredWord="Amiloride" semType="phsu, orch"/><RxNorm RxCui="142424"/></Normalization></entity><entity charOffset="29:43" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.3" text="spironolactone" type="Biomedical_Entity"><Normalization><mmtx cui="C0037982" phraseText="(spironolactone," preferredWord="Spironolactone" semType="strd, phsu"/><RxNorm RxCui="9997"/></Normalization></entity><entity charOffset="84:105" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.4" text="potassium supplements" type="Biomedical_Entity"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements" preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.0" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.1"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.0" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.2"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.0" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.3"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.0" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.4"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.1"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.3" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.1"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.1" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.4"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.3" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.2"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.4"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.3" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.4"/></sentence><sentence biomedicalEntities="0" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.95" lineNumber="123" text="If concomitant use of such agents is indicated, the patient's serum potassium should be monitored frequently." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94" Text="Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia. "/><anaphoraEntity charOffset="22:33" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.95.e.1" text="such agents" type="Expression"/><antecedentEntity charOffset="0:27" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.1" text="Potassium-sparing diuretics" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94" Text="Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia. "/><anaphoraEntity charOffset="22:33" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.95.e.1" text="such agents" type="Expression"/><antecedentEntity charOffset="84:105" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94.e.7" text="potassium supplements" type="Drug_Class"/></anaphoraRelation><entity charOffset="88:97" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.95.e.4" text="monitored" type="Caution_Interaction"/><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.95.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.95.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.95.e.1"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.93" text="Potassium Supplements and Potassium-Sparing Diuretics: Benazepril can attenuate potassium loss caused by thiazide diuretics. "><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.93.e.3"/></ellipsisSentence><middleSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.94" text="Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia. "/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.95.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96" lineNumber="124" text="Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium. " type="regular"><entity charOffset="9:24|33:39" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96.e.1" text="Increased serum levels" type="Increase_Interaction"/><entity charOffset="114:128" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96.e.2" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors during therapy" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="25:32" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96.e.3" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Increased serum lithium levels" preferredWord="Lithium" semType="phsu, elii"/><mmtx cui="C0023870" phraseText="Increased serum lithium levels" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="64:72" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96.e.5" text="toxicity" type="Increase_Interaction"><Normalization><mmtx cui="C0858786" phraseText="symptoms of lithium toxicity" preferredWord="toxic symptom" semType="sosy"/></Normalization></entity><entity charOffset="56:63" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96.e.6" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="symptoms of lithium toxicity" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96.ddi.2"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96.e.5"><relations><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96.e.3" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96.e.2" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96.e.6" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96.e.2" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.96.e.5" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.97" lineNumber="124" text="When coadministering Lotrel and lithium, frequent monitoring of serum lithium levels is recommended." type="regular"><entity charOffset="50:60" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.97.e.1" text="monitoring" type="Caution_Interaction"/><entity charOffset="21:27" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.97.e.2" text="Lotrel" type="Drug"><Normalization><mmtx cui="C0721438" phraseText="coadministering Lotrel" preferredWord="Lotrel" semType="phsu, orch"/><RxNorm RxCui="218090"/></Normalization></entity><entity charOffset="32:39" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.97.e.3" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="lithium," preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.97.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.97.e.1"><relations><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.97.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.97.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.97.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.97.e.3" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.97.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98" lineNumber="125" text="Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy." type="regular"><entity charOffset="82:93" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.1" text="hypotension" type="Specific_Interaction"/><entity charOffset="166:187" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.2" text="sodium aurothiomalate" type="Drug"><Normalization><mmtx cui="C0018034" phraseText="with injectable gold (sodium aurothiomalate" preferredWord="Gold Sodium Thiomalate" semType="phsu, orch"/><RxNorm RxCui="9853"/></Normalization></entity><entity charOffset="205:218" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.3" text="ACE inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="concomitant ACE inhibitor therapy." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="6:25" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.5" text="Nitritoid reactions" type="Specific_Interaction"><Normalization><mmtx cui="C0948404" phraseText="Nitritoid reactions" preferredWord="Nitritoid reaction" semType="dsyn"/></Normalization></entity><entity charOffset="44:59" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.7" text="facial flushing" type="Specific_Interaction"><Normalization><mmtx cui="C0016382" phraseText="facial flushing," preferredWord="Flushing" semType="sosy"/></Normalization></entity><entity charOffset="61:67" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.9" text="nausea" type="Specific_Interaction"><Normalization><mmtx cui="C0027497" phraseText="nausea," preferredWord="Nausea" semType="sosy"/></Normalization></entity><entity charOffset="69:77" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.11" text="vomiting" type="Specific_Interaction"><Normalization><mmtx cui="C0042963" phraseText="vomiting" preferredWord="Vomiting" semType="sosy"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.ddi.2"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.ddi.3"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.ddi.4"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.9"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.ddi.5"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.11"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.3" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.98.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99" lineNumber="126" text="Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with ACE inhibitors, including benazepril, may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="248:254" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.1" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="co-administration of NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="266:292" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.2" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors," preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="299:313" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.4" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="with ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="325:335" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.5" text="benazepril" type="Drug"><Normalization><mmtx cui="C0053091" phraseText="benazepril," preferredWord="benazepril" semType="phsu, orch"/><RxNorm RxCui="18867"/></Normalization></entity><entity charOffset="351:382" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.7" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="127:134" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.8" text="elderly" type="SPAN"/><entity charOffset="199:225" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.9" text="compromised renal function" type="SPAN"/><entity charOffset="136:151" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.10" text="volume-depleted" type="SPAN"/><entity charOffset="403:422" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.12" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><classClassMembership drugClass="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.2"/><drugClassMembership drug="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.5" drugClass="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.4"/><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.8"/></relation><relation type="hasContext"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.10"/></relation><relation type="hasContext"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.9"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.ddi.2"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.12"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.8"/></relation><relation type="hasContext"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.10"/></relation><relation type="hasContext"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.9"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.8, Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.10, Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.9" ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.1" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.4" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.99.e.7" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.101" lineNumber="126" text="Monitor renal function periodically in patients receiving benazepril and NSAID therapy." type="regular"><entity charOffset="0:7" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.101.e.1" text="Monitor" type="Caution_Interaction"/><entity charOffset="58:68" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.101.e.2" text="benazepril" type="Drug"><Normalization><mmtx cui="C0053091" phraseText="benazepril" preferredWord="benazepril" semType="phsu, orch"/><RxNorm RxCui="18867"/></Normalization></entity><entity charOffset="73:78" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.101.e.3" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.101.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.101.e.1"><relations><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.101.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.101.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.101.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.101.e.3" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.101.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.102" lineNumber="127" text="The antihypertensive effect of ACE inhibitors, including benazepril, may be attenuated by NSAIDs." type="regular"><entity charOffset="31:45" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.102.e.1" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="The antihypertensive effect of ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="57:67" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.102.e.2" text="benazepril" type="Drug"><Normalization><mmtx cui="C0053091" phraseText="benazepril," preferredWord="benazepril" semType="phsu, orch"/><RxNorm RxCui="18867"/></Normalization></entity><entity charOffset="4:27|76:86" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.102.e.4" text="antihypertensive effect attenuated" type="Specific_Interaction"/><entity charOffset="90:96" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.102.e.5" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="attenuated by NSAIDs." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugClassMembership drug="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.102.e.2" drugClass="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.102.e.1"/><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.102.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.102.e.4"><relations><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.102.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.102.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.102.e.1" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.102.e.5" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.102.e.4" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103" lineNumber="128" text="Antidiabetic agents: In rare cases, diabetic patients receiving an ACE inhibitor (including benazepril) concomitantly with insulin or oral antidiabetics may develop hypoglycemia. " type="regular"><entity charOffset="67:80" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.1" text="ACE inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="an ACE inhibitor" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="92:102" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.2" text="benazepril" type="Drug"><Normalization><mmtx cui="C0053091" phraseText="benazepril" preferredWord="benazepril" semType="phsu, orch"/><RxNorm RxCui="18867"/></Normalization></entity><entity charOffset="165:177" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.4" text="hypoglycemia" type="Specific_Interaction"><Normalization><mmtx cui="C0020615" phraseText="hypoglycemia." preferredWord="Hypoglycemia" semType="dsyn"/></Normalization></entity><entity charOffset="36:53" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.5" text="diabetic patients" type="SPAN"/><entity charOffset="123:130" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.6" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="concomitantly with insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="concomitantly with insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="concomitantly with insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="134:152" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.7" text="oral antidiabetics" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="oral antidiabetics" preferredWord="Antidiabetics" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><drugClassMembership drug="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.2" drugClass="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.1"/><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.4"><relations><relation type="hasContext"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.7"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.5" ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.1" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.6" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.4" type="Specific_Interaction"/><pair context="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.5" ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.1" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.7" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.4" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.6" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.7"/></sentence><sentence biomedicalEntities="0" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.104" lineNumber="128" text="Such patients should therefore be advised about the possibility of hypoglycemic reactions, and should be monitored accordingly." type="irregular"><entity charOffset="105:114" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.104.e.1" text="monitored" type="Caution_Interaction"/><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.104.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.104.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103" text="Antidiabetic agents: In rare cases, diabetic patients receiving an ACE inhibitor (including benazepril) concomitantly with insulin or oral antidiabetics may develop hypoglycemia. "><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.6"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103" text="Antidiabetic agents: In rare cases, diabetic patients receiving an ACE inhibitor (including benazepril) concomitantly with insulin or oral antidiabetics may develop hypoglycemia. "><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.1"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103" text="Antidiabetic agents: In rare cases, diabetic patients receiving an ACE inhibitor (including benazepril) concomitantly with insulin or oral antidiabetics may develop hypoglycemia. "><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.103.e.7"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="3" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105" lineNumber="129" text="Dual Blockade of the Renin-Angiotensin System (RAS): Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. " type="irregular"><entity charOffset="181:192" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.1" text="hypotension" type="Specific_Interaction"/><entity charOffset="83:112" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.2" text="angiotensin receptor blockers" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="133:142" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.3" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="114:128" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.4" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="194:206" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.6" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="212:237" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.8" text="changes in renal function" type="Specific_Interaction"/><entity charOffset="249:268" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.10" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.4"/></relation><relation type="hasObject"><labelDrug text="Lotrel"/><normalization><mmtx><preferredWord>Lotrel</preferredWord><phraseText>Lotrel in patients</phraseText><cuiCode>C0721438</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.ddi.2"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.4"/></relation><relation type="hasObject"><labelDrug text="Lotrel"/><normalization><mmtx><preferredWord>Lotrel</preferredWord><phraseText>Lotrel in patients</phraseText><cuiCode>C0721438</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.ddi.3"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.4"/></relation><relation type="hasObject"><labelDrug text="Lotrel"/><normalization><mmtx><preferredWord>Lotrel</preferredWord><phraseText>Lotrel in patients</phraseText><cuiCode>C0721438</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.ddi.4"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.10"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.4"/></relation><relation type="hasObject"><labelDrug text="Lotrel"/><normalization><mmtx><preferredWord>Lotrel</preferredWord><phraseText>Lotrel in patients</phraseText><cuiCode>C0721438</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.3"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.4"/><pair ddi="false" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.4" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.105.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.106" lineNumber="129" text="Closely monitor blood pressure, renal function and electrolytes in patients on Lotrel and other agents that block the RAS." type="regular"><entity charOffset="8:15" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.106.e.1" text="monitor" type="Caution_Interaction"/><entity charOffset="96:121" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.106.e.2" text="agents that block the RAS" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="other agents" preferredWord="Pharmacologic Substance" semType="phsu"/><mmtx cui="C0035100" phraseText="the RAS." preferredWord="Chymosin" semType="phsu, aapp, enzy"/><mmtx cui="C0003018" phraseText="the RAS." preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="126263"/></Normalization></entity><entity charOffset="79:85" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.106.e.3" text="Lotrel" type="Drug"><Normalization><mmtx cui="C0721438" phraseText="on Lotrel" preferredWord="Lotrel" semType="phsu, orch"/><RxNorm RxCui="218090"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.106.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.106.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.106.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.106.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.106.e.3" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.106.e.2" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.106.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.107" lineNumber="130" text="Do not co-administer aliskiren with Lotrel in patients with diabetes. " type="regular"><entity charOffset="0:20" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.107.e.1" text="Do not co-administer" type="Caution_Interaction"/><entity charOffset="21:30" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.107.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with Lotrel" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="36:42" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.107.e.3" text="Lotrel" type="Drug"><Normalization><mmtx cui="C0721438" phraseText="aliskiren with Lotrel" preferredWord="Lotrel" semType="phsu, orch"/><RxNorm RxCui="218090"/></Normalization></entity><entity charOffset="60:68" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.107.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes." preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes." preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.107.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.107.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.107.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.107.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.107.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.107.e.4" ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.107.e.2" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.107.e.3" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.107.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.108" lineNumber="130" text="Avoid use of aliskiren with Lotrel in patients with renal impairment (GFR 60 ml/min)." type="regular"><entity charOffset="0:5" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.108.e.1" text="Avoid" type="Caution_Interaction"/><entity charOffset="28:34" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.108.e.2" text="Lotrel" type="Drug"><Normalization><mmtx cui="C0721438" phraseText="with Lotrel" preferredWord="Lotrel" semType="phsu, orch"/><RxNorm RxCui="218090"/></Normalization></entity><entity charOffset="52:68" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.108.e.3" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><entity charOffset="13:22" id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.108.e.4" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><drugInteraction id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.108.ddi.1"><interaction trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.108.e.1"><relations><relation type="hasObject"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.108.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.108.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.108.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.108.e.3" ddi="true" e1="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.108.e.4" e2="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.108.e.2" trigger="Dailymed.94ae6054-b7ae-4212-a567-4f803af8f2c7.s.108.e.1" type="Caution_Interaction"/></sentence><positiveExamples number="40"/><negativeExamples number="58"/></document>